[96a5a0]: / output / allTrials / identified / NCT06500494_identified.json

Download this file

282 lines (282 with data), 12.2 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
{
"info": {
"nct_id": "NCT06500494",
"official_title": "Advanced Breast Cancer Patients Treated With Oral Vinorelbine: a Prospective and Retrospective, Observational Study - VINOREAL",
"inclusion_criteria": "Female aged ≥ 18 years (≥ 19 years for Algeria as per local regulation) at oral vinorelbine ( OV) -based treatment initiation\n\nConfirmed diagnosis of locally advanced or metastatic breast cancer eligible for chemotherapy\n\nInitiated OV-based treatment as per SmPC for advanced breast cancer between January 2011 and December 2020 for the retrospective cohort or, initiating oral vinorelbine treatment at enrollment for the prospective cohort\n\nWilling and able to complete the QoL questionnaire, PPQ and WPAI questionnaire for the prospective cohort\n\nProvision of informed consent or non-opposition to the patient (or next of kin/legal representative, if applicable) for the use of data, according to local regulations\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "no exclusion criteria for patients in this study",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "Female aged ≥ 18 years (≥ 19 years for Algeria as per local regulation) at oral vinorelbine ( OV) -based treatment initiation",
"criterions": [
{
"exact_snippets": "Female",
"criterion": "gender",
"requirements": [
{
"requirement_type": "value",
"expected_value": "female"
}
]
},
{
"exact_snippets": "aged ≥ 18 years (≥ 19 years for Algeria as per local regulation)",
"criterion": "age",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "years"
}
]
}
},
{
"requirement_type": "value",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 19,
"unit": "years"
}
]
}
}
]
},
{
"exact_snippets": "oral vinorelbine ( OV) -based treatment initiation",
"criterion": "treatment initiation",
"requirements": [
{
"requirement_type": "treatment type",
"expected_value": "oral vinorelbine-based"
}
]
}
]
},
{
"line": "Confirmed diagnosis of locally advanced or metastatic breast cancer eligible for chemotherapy",
"criterions": [
{
"exact_snippets": "Confirmed diagnosis of locally advanced or metastatic breast cancer",
"criterion": "breast cancer diagnosis",
"requirements": [
{
"requirement_type": "confirmation",
"expected_value": true
},
{
"requirement_type": "stage",
"expected_value": [
"locally advanced",
"metastatic"
]
}
]
},
{
"exact_snippets": "eligible for chemotherapy",
"criterion": "chemotherapy eligibility",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": true
}
]
}
]
},
{
"line": "Initiated OV-based treatment as per SmPC for advanced breast cancer between January 2011 and December 2020 for the retrospective cohort or, initiating oral vinorelbine treatment at enrollment for the prospective cohort",
"criterions": [
{
"exact_snippets": "Initiated OV-based treatment as per SmPC for advanced breast cancer between January 2011 and December 2020 for the retrospective cohort",
"criterion": "OV-based treatment initiation",
"requirements": [
{
"requirement_type": "timeframe",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 2011,
"unit": "year"
},
{
"operator": "<=",
"value": 2020,
"unit": "year"
}
]
}
},
{
"requirement_type": "condition",
"expected_value": "advanced breast cancer"
}
]
},
{
"exact_snippets": "initiating oral vinorelbine treatment at enrollment for the prospective cohort",
"criterion": "oral vinorelbine treatment initiation",
"requirements": [
{
"requirement_type": "timing",
"expected_value": "at enrollment"
}
]
}
]
},
{
"line": "Willing and able to complete the QoL questionnaire, PPQ and WPAI questionnaire for the prospective cohort",
"criterions": [
{
"exact_snippets": "Willing and able to complete the QoL questionnaire",
"criterion": "QoL questionnaire completion",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
},
{
"requirement_type": "ability",
"expected_value": true
}
]
},
{
"exact_snippets": "Willing and able to complete the ... PPQ",
"criterion": "PPQ completion",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
},
{
"requirement_type": "ability",
"expected_value": true
}
]
},
{
"exact_snippets": "Willing and able to complete the ... WPAI questionnaire",
"criterion": "WPAI questionnaire completion",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
},
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "Provision of informed consent or non-opposition to the patient (or next of kin/legal representative, if applicable) for the use of data, according to local regulations",
"criterions": [
{
"exact_snippets": "Provision of informed consent or non-opposition to the patient (or next of kin/legal representative, if applicable) for the use of data",
"criterion": "informed consent or non-opposition",
"requirements": [
{
"requirement_type": "provision",
"expected_value": true
}
]
},
{
"exact_snippets": "according to local regulations",
"criterion": "compliance with local regulations",
"requirements": [
{
"requirement_type": "compliance",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "no exclusion criteria for patients in this study",
"criterions": [
{
"exact_snippets": "no exclusion criteria",
"criterion": "exclusion criteria",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}